HB 2364 Kansas House · 2025-2026 Regular Session

Prohibiting certain health insurers from requiring cost-sharing for nonopioid prescription drugs or providing less favorable coverage for such drug than that for opioid or narcotic prescription drugs for the treatment of pain.

HB 2364 requires health insurers (including Medicaid, CHIP, and state employee plans) to provide equal coverage for FDA-approved nonopioid pain medications as for opioid or narcotic drugs. Specifically, insurers cannot deny coverage for nonopioid drugs in favor of opioids, force patients to try opioids first, or impose higher out-of-pocket costs (like copays or stricter prior authorization) on nonopioid drugs compared to opioids. The bill ensures nonopioid pain medications are not disadvantaged in formulary tiers or coverage rules. It directly affects patients prescribed nonopioid pain treatments and insurers managing drug coverage. The law takes effect upon publication in the statute book.
Bill status died 3 of 5 stages cleared
Introduction
Feb 2025
Committee Review
Feb 2026
House Passage
Feb 2026
Senate Passage
Governor
Introduced Feb 7, 2025 Last action Apr 10, 2026
Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
8
Key actions
3
Committee
3
Feb 19, 2026
Committee
Referred to Senate Committee on Public Health and Welfare
upper
Feb 18, 2026
Introduced
Received and Introduced
upper
Feb 18, 2026
Lower · Passed
Final Action - Passed; Yea 123, Nay 1, Absent 1
lower
Feb 17, 2026
Lower · Passed
Committee of the Whole - Be passed
lower
Feb 10, 2026
Lower · Passed
Committee Report recommending bill be passed by House Committee on Health and Human Services
lower
Feb 7, 2025
Committee
Referred to House Committee on Health and Human Services
lower
Feb 7, 2025
Introduced
Introduced
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.